BACKGROUND: Colorectal cancer (CRC) rates in low-resource countries, which typically lack CRC screening programs, are rising. This study determined whether a risk model for patients with rectal bleeding could identify patients with curable CRC. METHODS: This prospective, cross-sectional study evaluated a model constructed from data from 1 hospital and validated at 2 other hospitals. The primary endpoint was the ability of the model to predict CRC, as diagnosed by colonoscopy, from clinical characteristics. The secondary endpoint was to determine the percentage of patients who had CRC. RESULTS: Consecutive patients who were 45 years old or older and had self-reported rectal bleeding for more than 1 week were evaluated. From January 2014 to July 2016, 362 patients answered a questionnaire and underwent colonoscopy. In the validation cohort, 56% of patients with rectal bleeding, weight loss, and changes in bowel habits had CRC, whereas 2% of patients with bleeding alone did. Overall, 18.2% of the patients had CRC, and 8.6% had adenomas. The proportion of CRC patients with potentially curable stage II or III disease was 74%, whereas the historical rate was 36%. The combination of rectal bleeding with both symptoms significantly predicted CRC in the validation set (odds ratio, 12.8; 95% confidence interval, 4.6-35.4; P <.001). CONCLUSIONS: In low-resource settings, patients with rectal bleeding, weight loss, and changes in bowel habits should be classified as high risk for CRC. Patients with a high risk score should be prioritized for colonoscopy to increase the number of patients diagnosed with potentially curable CRC. Cancer 2018;124:2766-73.
INTRODUCTION
Cancer is a major public health issue in most low-and middle-income countries (LMICs). Colorectal cancer (CRC), traditionally thought to exist primarily in high-income countries, is increasing in many LMICs as industrialization and lifestyle changes alter risk factors.
1,2 The short-and long-term outcomes for patients in LMICs with CRC are poor. 3, 4 In Nigeria, the location of the current study, we found prospectively that patients diagnosed with CRC have a 1-year survival rate of 47% (O.I.A. and T.P.K., unpublished data, 2017). As many as 99% of patients with CRC in LMICs present emergently with locally advanced (stage III) or metastatic (stage IV) disease. 4 Survival is strongly related to the stage at diagnosis: 5-year survival is greater than 90% for patients with stage I CRC but is only 10% for patients with stage IV CRC. [5] [6] [7] In addition, the cost of treatment rises significantly as the stage of the disease increases. 8 Two strategies are commonly used to detect early-stage CRC: population-based CRC screening and early-diagnosis strategies in symptomatic patients. 9, 10 Screening for CRC leads to a reduction in emergency presentations, a reduction in the proportion of cancers with adenomatous polyps (adenomas), and a shift to a diagnosis at earlier stages. 11 Screening also allows an increase in the proportion of patients managed with curative intent, even in resource-limited communities. 11 Recent modeling studies suggest that CRC screening can be effective in LMICs. 12, 13 In sub-Saharan Africa, however, there are no published prospective studies testing CRC screening methods, no screening programs, and no evidence-based screening guidelines using prospectively collected data. The screening of asymptomatic individuals for microscopic blood in the stool may appear to be cost-effective in LMICs such as Nigeria, but this method is challenging because a high prevalence of non-cancer-related rectal bleeding and limited resources make it hard to justify colonoscopies, which seldom diagnose CRC. 14, 15 An alternative strategy is symptom-based screening to identify high-risk patients, as has been suggested for highincome countries to facilitate the diagnosis of early-stage CRC. [16] [17] [18] [19] [20] [21] [22] [23] In resource-limited environments, however, there are no prospective data on the outcomes of symptom-based referrals for colonoscopy.
Given the importance of generating local evidence for CRC screening, we conducted a prospective, multicenter, cross-sectional study at 3 academic institutions in Nigeria with facilities for routine endoscopy. The trial consisted of colonoscopy in high-risk patients with rectal bleeding. On the basis of our retrospective colonoscopy data, 15 we hypothesized that colonoscopy would demonstrate that 10% to 20% of these patients had CRC or premalignant colorectal adenomatous polyps.
MATERIALS AND METHODS

Study Design and Setting
The setting was 3 hospitals from the African Research Group for Oncology consortium in southwest Nigeria: the Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC) in Ile-Ife, Osun State; the University College Hospital (UCH) in Ibadan, Oyo State; and the University of Ilorin Teaching Hospital (UITH)in Ilorin, Kwara State. The human subjects committee of each institution approved the study. Patients provided written informed consent. The study was registered with ClinicalTrials.gov (NCT03032874).
The design was a prospective, multicenter, crosssectional study involving patients with rectal bleeding who underwent complete colonoscopy from January 2014 to July 2016 at the endoscopy units at the participating institutions. We used patients from OAUTHC to create a set for a training model to predict cancer risk and patients from UCH and UITH to validate this model. Because OAUTHC accrued patients much faster than UCH and UITH, we set a target of at least 75 patients for the validation set and allowed the training set to accrue until the validation enrollment targets were reached. With this strategy, 217 patients were accrued at OAUTHC. Although it is difficult to provide power calculations for building a predictive model, this gave us approximately 83% power to detect a univariate association with a binary predictor and the outcome of a CRC diagnosis. This calculation assumed a 5% type 1 error and CRC rates of 5% and 22% in the 2 symptom groups created by the binary predictor. At all 3 centers, a questionnaire on demographics and symptoms was completed for each of the patients. No patients dropped out between the time of questionnaire completion and the time of colonoscopy because they were performed on the same day. The questionnaire was based on National Cancer Institute CRC risk factors for patients in high-income countries. 24 Before the research began at each center, an update course was conducted for community health workers and primary care physicians who practiced within a 45-minute driving distance from the teaching hospitals. This ensured education about rectal bleeding and CRC for physicians at many of the community health centers and along the patient referral pathway. In addition, educational talks by the authors (O.I.A., T.P.K., O.O.A., and A.A.) were broadcast on television and radio in the cities where the studies were conducted.
Eligibility Criteria
The inclusion criteria included an age of 45 years or older, rectal bleeding lasting at least 1 week, and a complete colonoscopy. The exclusion criteria included a history of inflammatory bowel disease, colorectal polyps, or CRC; a family history of hereditary polyposis syndromes; hereditary nonpolyposis CRC; or an individual history of colectomy.
Preprocedure Evaluation and Study Procedure
A custom-designed questionnaire was used to gather demographic data, the rectal bleeding history, and any relevant medical history. This questionnaire was pilot-tested in a previous study examining attitudes about rectal bleeding in Nigerian patients. 25 All colonoscopies were performed by endoscopists who performed at least 100 procedures per year. Complete colonoscopy was defined as visualization of the cecum, as confirmed by the iliocecal valve, ileal intubation, or identification of the appendiceal orifice. [26] [27] [28] African Research Group for Oncology staff, based at OAUTHC, collated completed questionnaires from the other 2 institutions after every 5 patients. Incomplete data sets were highlighted and reported to the respective coordinators. To obtain missing data, the research coordinators contacted patients. The protocol included financial support for patients diagnosed with CRC to undergo surgery, which included coverage of staging scans and surgery (usually less than $600 in total). All cancer patients were staged by computed tomography scanning, during surgery, or by a combination of the two.
Data Analysis
The primary endpoint was the ability of the model developed in this study to predict CRC. The secondary endpoints were the percentage of study participants who had CRC diagnosed upon colonoscopy, the percentage with adenomas, the percentage presenting with stage I or II CRC in comparison with historical controls in Nigeria, and the safety of colonoscopy in the study cohort. A change in bowel habits was coded as any change in bowel habits (yes/no). Unintentional weight loss within the last 6 months (yes/no) was described to patients as looseness of clothes, belts, and wristwatches. Some patients provided objective weight-loss information for the preceding 6 months.
Data were stored in a password-protected database on a secure Web site. We created the predictive model from the training set by first conducting univariate tests of association. Categorical variables were compared with the chi-square test or Fisher exact test, whereas quantitative variables were compared with the Kruskal-Wallis test. Variables significantly associated in this univariate analysis were included in a logistic regression model to build a predictive model. Predictions using this model were obtained for the validation-set patients, and the ability of these predictions to discriminate patients with cancer from those without cancer was evaluated with the c-index.
All statistical tests were 2-sided, and P values less than .05 were considered significant. Statistical analysis was performed with SAS 9.4 and R 3.3.1.
RESULTS
In total, 362 patients were enrolled: 217 (60%) at OAUTHC and 145 (40%) at the other 2 participating institutions (UCH and UITH). The patients at OAUTHC constituted the training set for a prediction model, and those at UCH and UITH were used as a validation set. In the combined cohorts, most commonly, patients saw blood in their stool once or twice per week (n 5 171 [47.2%]; Table 1 ). Patients frequently believed that hemorrhoids were the cause of their rectal bleeding (n 5 172 [47.5%]). The training and validation sets had no statistically significant differences in median age, sex distribution, or body mass index, but they had some significant differences in patient beliefs regarding the etiology of bleeding and symptoms, such as the frequency of blood in stool (Table 1) . Only 4 patients (1.1%) reported a complication from the colonoscopy procedure. These complications included excessive abdominal distension and severe vomiting from sedatives. None required hospital admission, and all resolved within 24 hours of the procedure.
The source of bleeding, diagnosed by colonoscopy, was most commonly hemorrhoids (n 5 120 [33.1%]), which were followed by diverticulosis (n 5 81 [22.4%]) and CRC (n 5 65 [18.0%]). In approximately 13% of the patients, the cause of bleeding could not be ascertained by colonoscopy. Most colonoscopy findings were not significantly different between the training and validation groups ( Table 2 ). The overall rate of adenoma detection was 8.6% (n 5 31), and the overall rate of cancer detection was 18.2% (n 5 66). Nine adenomas (29%) and 8 CRCs (12%) were found in the right colon. Most CRCs were not metastatic (stage II, 29%; stage III, 45%). The percentage of stage II patients was significantly higher at OAUTHC than the other 2 centers (42% vs 11%; 
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To determine factors that could predict a finding of CRC, we evaluated the association of demographic and clinical characteristics with colonoscopy findings in the training set (Table 3 ). Patients with CRC had a significantly lower body mass index (22.9 kg/m 2 ) than patients without CRC (24.9 kg/m 2 ; P 5 .009). Patients with CRC also had a significantly lower proportion of internal hemorrhoids (61% vs 90%; P < .001). Weight loss and changes in bowel habits were more common in CRC patients than those without CRC (P < .0001). When we were building the model on the training set, weight loss (odds ratio, 7.9; 95% confidence interval, 2.8-21.8; P < .0001) and a change in bowel habits (odds ratio, 6.3; 95% confidence interval, 2.3-17.6; P 5 .0004) were significant predictors. There was also evidence of a synergistic interaction between these variables, although in a traditional multivariate model, the interaction term was not statistically significant. We, therefore, opted for a univariate model based on a symptom score, which was coded as 0, 1, or 2 according to whether the patient had 0, 1, or both of the symptoms (weight loss and a change in bowel habits). Overall, CRC was present in only 1.4% of the patients with no weight loss or changes in bowel habits but in 49% of the patients with a symptom score of 2 (ie, both weight loss and a change in bowel habits). The symptom score was highly significant in predicting CRC in the validation set with patients with both symptoms versus no symptoms (odds ratio, 12.8; 95% confidence interval, 4.6-35.4; P < .001). The concordance index in the validation set was 0.875 (Table 4) . When age was added to the final model, the concordance was 0.7467, so its incremental value was not significant. When a symptom score of 2 was used as positive, then the specificity for diagnosing CRC was 83%, and the sensitivity was 89%. The symptom score was not associated with stage (P 5 .50; Table  5 ). For example, weight loss and a change in bowel habits had similar distributions among stages II through IV.
DISCUSSION
Screening offers a means of shifting the CRC diagnosis to earlier stages and thus improving the poor outcomes in sub-Saharan Africa. However, large-scale asymptomatic CRC screening is unlikely to be possible in the near future in this region. We prospectively examined the utility of identifying high-risk Nigerian patients with rectal bleeding and then evaluating them with colonoscopy. We found that 18.2% of patients who were 45 years old or older and had rectal bleeding for more than 1 week had CRC. For a patient with rectal bleeding, a simple symptom score based on weight loss and changes in bowel habits was associated with CRC with an odds ratio of 12.8. In the validation cohort, fully 89% of the cancers were in patients with a symptom score of 2, and this suggests that this model may have excellent sensitivity among patients with rectal bleeding. Overall, CRC was present in only 1.4% of patients with a symptom score of 0 but in 49% of patients with a symptom score of 2 (ie, both weight loss and a change in bowel habits). These findings demonstrate that in low-resource environments, it is possible to identify patients likely to harbor CRC with a combination of symptoms. Most importantly, 74% of the cancers were stage II or III, whereas historical data in Nigeria show that only 36% of CRCs were stage II or III at diagnosis (O.I.A. and T.P.K., unpublished data). Outside sub-Saharan Africa, numerous studies have evaluated patients with rectal bleeding to determine the risk of polyps and CRC in this population. The CRC risks associated with rectal bleeding, weight loss, and changes in bowel habits in our study were higher than those reported in most studies outside sub-Saharan Africa. The positive predictive value of rectal bleeding in our study (18.2%) contrasts with the values reported in a meta-analysis, in which values ranged from 2.2% to 16%. The higher positive predictive value seen in our study is likely multifactorial. Many of the patients in our study had other symptoms in addition to bleeding. It is possible that patients referred for colonoscopy are identified at community health centers or by primary physicians as high-risk because of these symptoms or their clinical suspicion of CRC. This stresses the need for a community-based study of asymptomatic patients with rectal bleeding in West Africa because it is unknown what regional differences may exist for CRC risk in this population. The meta-analysis showed a positive predictive value for rectal bleeding that ranged from 2.2% to 16% in the 13 included studies, and the pooled positive predictive value reached 8.1% in those 50 years old. The analysis also revealed a higher risk when rectal bleeding was combined with other symptoms (eg, pooled positive likelihood ratios of 1.9 for weight loss and 1.8 for changes in bowel habits). 29 The positive likelihood ratios were higher for our validation cohort (2.32 for a change in stool and 3.89 for weight loss). One study at tertiary hospitals in the United Kingdom found 181 CRC patients among 2697 subjects (6.7%) with rectal bleeding, changes in bowel habits, and abdominal pain. 30 Cancer control plans are currently being generated in many countries in sub-Saharan Africa. The data presented here provide an important component of CRC control planning. Recognition of the importance of the symptom complex of rectal bleeding, weight loss, and changes in bowel habits should lead to systematic education of primary care physicians to refer patients with these symptoms early for surveillance colonoscopies. It is possible that this will lead to a stage migration so that CRC is prevented for patients with polyps and so that patients with CRC are diagnosed at an earlier, more curable stage. Similar programs exist in high-income countries, where, as adjuncts to organized CRC screening programs, they reduce morbidity and mortality. 14, [16] [17] [18] [19] [20] [21] [22] 31 In this context, some practice guidelines, such as the updated National Institute for Health and Care Excellence guidelines in the United Kingdom, recommend urgent referral of all patients 40 years old or older who report rectal bleeding with a change toward looser stools and/or increased stool frequency persisting for 2 weeks or more. 32 The incidence of CRC is lower in most LMICs than high-income countries, 33 but it is rising. Although this may justify organized screening for CRC in the future, the The argument against the use of symptom-based surveillance for CRC is that these symptoms are common in populations without cancer and so may have poor sensitivity for CRC. 34, 35 Hence, evaluating patients at low risk for CRC may lead to unnecessary harm, which could include cost, patient anxiety, and iatrogenic injury. 32 However, the high yield of CRC in this study (18.2%) shows that the risk of CRC among Nigerians with a median of 6 months of rectal bleeding may actually be higher than previously estimated and so justifies recommending the referral of patients much earlier than 6 months into their bleeding so that they can undergo colonoscopy surveillance. In addition, the high rate of CRC in comparison with adenomatous polyps in this patient population again confirms that this is surveillance of a highrisk group. It could also be argued that the symptom complex (rectal bleeding, weight loss, and changes in bowel habits) connotes a late presentation. Our data clearly demonstrate that the symptoms are not unique to a late presentation.
In this study, more than 80% of the study cohort had consulted a physician before enrollment. Unfortunately, most patients were not originally referred for colonoscopy. In previous studies in both high-income countries and LMICs, only 28% to 41% of patients with rectal bleeding consulted a physician. 34, [36] [37] [38] A reason for the higher consultation rate for rectal bleeding in the current study is the Nigerian cultural belief that seeing blood from any part of the body is an ominous sign that requires early treatment. This makes rectal bleeding a useful tool for investigating CRC in Nigeria.
In our cohorts, the right colon was the location for approximately 30% of adenomatous polyps and 12% of CRCs. Most of these cases would have been missed by sigmoidoscopy. This suggests that colonoscopy may be superior to sigmoidoscopy for screening patients with rectal bleeding. Similarly high proportions of right-sided adenomatous polyps and CRCs have also been reported in a single-center study from Iran. 16 The strengths of this study are that it is both multicentric and prospective. It begins to fill the massive gap in data to form the basis for evidence-based CRC screening in Africa. The study also has limitations. Some patients were given bowel prep supplies but never returned to be enrolled in the study, so they did not complete a questionnaire or undergo colonoscopy. These patients were not followed, so the characteristics of these patients are unclear. There was likely a selection bias among the patients referred to the study because of the high rates of patients with CRC (18%) and adenomatous polyps (9%). It is possible that the education level of the referring physicians had an effect on the profile of the patients referred. This pattern was consistent, however, among all 3 cities. In addition, the study did not evaluate the surveillance method for cost-effectiveness in LMICs such as Nigeria. Despite these limitations, this is the first prospective, cross-sectional study to determine CRC downstaging in patients with rectal bleeding stratified by the symptoms of weight loss and changes in bowel habits.
In conclusion, the risk model developed and validated in this study has high sensitivity and specificity. It can be used to provide evidence-based recommendations for cancer control plans in sub-Saharan Africa with the hope that such usage will lead to an improvement in the poor outcomes for patients with CRC in LMICs.
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